Cellebrite DI (CLBT)vsVuzix Corp Cmn Stk (VUZI)
CLBT
Cellebrite DI
$14.57
-3.32%
TECHNOLOGY · Cap: $3.83B
VUZI
Vuzix Corp Cmn Stk
$2.14
-4.89%
TECHNOLOGY · Cap: $187.94M
Smart Verdict
WallStSmart Research — data-driven comparison
Cellebrite DI generates 8050% more annual revenue ($496.43M vs $6.09M). CLBT leads profitability with a 14.5% profit margin vs 0.0%. CLBT earns a higher WallStSmart Score of 40/100 (F).
CLBT
Hold40
out of 100
Grade: F
VUZI
Avoid16
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-36.0%
Fair Value
$10.92
Current Price
$14.57
$3.65 premium
Margin of Safety
+40.2%
Fair Value
$4.13
Current Price
$2.14
$1.99 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
19.3% revenue growth
Conservative balance sheet, low leverage
Areas to Watch
Distress zone — elevated risk
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 42.9%
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -90.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CLBT
The strongest argument for CLBT centers on Debt/Equity, Revenue Growth. Revenue growth of 19.3% demonstrates continued momentum.
Bull Case : VUZI
The strongest argument for VUZI centers on Debt/Equity.
Bear Case : CLBT
The primary concerns for CLBT are Altman Z-Score, Piotroski F-Score, P/E Ratio. A P/E of 54.9x leaves little room for execution misses.
Bear Case : VUZI
The primary concerns for VUZI are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
CLBT profiles as a growth stock while VUZI is a value play — different risk/reward profiles.
VUZI carries more volatility with a beta of 1.75 — expect wider price swings.
CLBT is growing revenue faster at 19.3% — sustainability is the question.
CLBT generates stronger free cash flow (17M), providing more financial flexibility.
Bottom Line
CLBT scores higher overall (40/100 vs 16/100) and 19.3% revenue growth. VUZI offers better value entry with a 40.2% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cellebrite DI
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors globally. The company is headquartered in Petah Tikva, Israel.
Vuzix Corp Cmn Stk
TECHNOLOGY · CONSUMER ELECTRONICS · USA
Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.
Compare with Other SOFTWARE - INFRASTRUCTURE Stocks
Want to dig deeper into these stocks?